Intravenous Infusions Plc (GHSE:IIL)
Ghana · Delayed Price · Currency is GHS 0.0500
0.00 (0.00%)
At close: Feb 16, 2026
Intravenous Infusions Market Cap
Intravenous Infusions has a market cap or net worth of 13.72 million as of February 20, 2026. Its market cap has decreased by -32.73% in one year.
Market Cap
13.72M
Enterprise Value
23.83M
Revenue
9.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since December 17, 2015, Intravenous Infusions's market cap has decreased from 18.13M to 13.72M, a decrease of -24.32%. That is a compound annual growth rate of -2.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 16, 2026 | 13.72M | - |
| Dec 4, 2025 | 13.72M | - |
| Dec 22, 2023 | 13.72M | 6.02% |
| Dec 22, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Benso Oil Palm Plantation | 2.30B |
| Unilever Ghana | 1.56B |
| GOIL Plc | 1.55B |
| Fan Milk | 1.42B |
| Republic Bank (Ghana) | 1.28B |
| Enterprise Group | 769.02M |
| Trust Bank | 480.00M |
| SIC Insurance | 401.07M |